ABCL 424B5: Secondary offering
Filed with the SEC on · accession 0001193125-26-349333
ABCL filed a 424B5 (prospectus (offering)) with the SEC on Aug 13, 2026. The final terms of an offering of shares or bonds. The stock moved +5.9% by the first close after the filing.
Summary of the filing
AbCellera Biologics Inc. is offering 17,435,897 common shares and pre-funded warrants to purchase up to 3,076,926 common shares in a public offering at $9.75 per share, with expected gross proceeds of approximately $200 million.
Key details
How ABCL stock reacted
Close before
$10.36
Aug 12, 2026
First close after
+5.94%
$10.97
5 trading days
+15.98%
$12.01
Since filing
+20.71%
$12.50
✦ Ask GOAX AI about this filing — what it means for ABCL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ABCL?
Click hereFrequently asked questions
What did ABCL file with the SEC on Aug 13, 2026?
ABCL filed a 424B5 (Secondary offering). AbCellera Biologics Inc. is offering 17,435,897 common shares and pre-funded warrants to purchase up to 3,076,926 common shares in a public offering at $9.75 per share, with expected gross proceeds of approximately $200 million.
What does a secondary offering mean for ABCL stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did ABCL stock react to this filing?
ABCL closed at $10.36 before the filing and $10.97 on Aug 13, 2026 (+5.94%). Five trading days later: $12.01 (+15.98%).
Other ABCL SEC filings
- 8-K · SEC filingNov 9, 2026
- 8-K · Secondary offeringAug 13, 2026
- 424B5 · Secondary offeringAug 11, 2026
- 8-K · Fda approvalAug 10, 2026
- 8-K · Fda approvalAug 7, 2026
- 8-K · SEC filingAug 5, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · Material agreementJul 29, 2026
- 8-K · Board changeJul 6, 2026
- 8-K · Material agreementJun 17, 2026
Get alerts when ABCL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days